Author:
Wang Tao,Jacobson-Kram David,Pilaro Anne M.,Lapadula Daniel,Jacobs Abigail,Brown Paul,Lipscomb John,McGuinn William David
Publisher
Oxford University Press (OUP)
Reference16 articles.
1. Ras oncogenes in human cancer: a review;Cancer Res.,1989
2. Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?;Regul. Toxicol. Pharmacol.,2008
3. Regulatory considerations for preclinical development of anticancer drugs;Cancer Chemother. Pharmacol.,1998
4. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis;Cancer Res.,1994
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Regulatory Toxicology;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024
2. Oncology Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2023
3. Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET;Journal of Nuclear Medicine;2022-04-28
4. Mutagenic Toxicity Testing;Introduction to Basics of Pharmacology and Toxicology;2022
5. In vivo safety testing of Antibody Drug Conjugates;Regulatory Toxicology and Pharmacology;2021-06